Article Name China

Cytokinetics and Sanofi partner to develop aficamten in Greater China

Sanofi secures rights to advance and commercialize aficamten for cardiac care....Read more

20th December, 2024


Everest Medicines announces first VELSIPITY prescription in Greater Bay Area

Everest Medicines marking a milestone in benefiting Mainland China patients...Read more

18th December, 2024


MGI Tech, Dasa partner to enhance genetic sequencing-based health diagnosis in Brazil

New technologies will contribute advancing personalized medicine in the country...Read more

18th September, 2024


Hong Kong develops next-gen wearable continuous glucose monitoring system for diabetes management

Features a compact, coin-sized design integrating state-of-the-art biosensors, minimally invasive tools, and hydrogels...Read more

18th September, 2024


Concord Medical received large medical equipment procurement license for proton therapy equipment

To offer proton therapy treatment services at its proton center...Read more

16th September, 2024


PolyU and Suzhou Kowloon Hospital to establish incubation platform advancing medical technology in China

A biomedical technology innovation incubator will be established...Read more

13th September, 2024


China’s Venus Medtech completes first implantations of its in-house TAVR system

Technology to enable aortic stenosis treatment while maintaining coronary access...Read more

05th September, 2024


China's Huawei unveils new TruSense system to support healthcare wearables

Digital health ecosystem to participate in shaping the future of health and fitness technology...Read more

29th August, 2024


China’s UTime Limited announces new AI health strategy, strategic collaboration

To extend into hemodynamic and health mapping products...Read more

21st August, 2024


China Pharma Holdings to launch dry eye disease therapeutic device in Q1, 2025

A medical treatment device for dry eye disease under patent protection...Read more

19th August, 2024


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer